Back to All Events

Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents


image001.jpg

Sponsored by the Division of Cancer Prevention, National Cancer Institute

Meeting Objectives:

The main goals of this workshop are to 1) foster the exchange of ideas and potentially new collaborative interactions among leading cancer immunoprevention researchers from the basic and clinical research areas, 2) highlight new and emerging trends in immunoprevention, and 3) provide an opportunity for new or experienced cancer prevention investigators who want to explore immunoprevention in their research studies.

 

Agenda Topics:

·       Patient Advocates Forum

·       Early Discovery Research on Immunomodulatory Agents for Cancer Prevention

·       Combinations of Immunomodulators with Cancer Preventive Agents or Vaccines

·       Immune Checkpoint Inhibitors in Immunoprevention

 

For More Information and Registration:

https://events.cancer.gov/cadrg/tacpad

 

 

Meeting Organizers:

 

Mark Steven Miller, Ph.D.

Program Director, National Cancer Institute

Email: mark.miller5@nih.gov

Phone: 240-276-5004

 

Altaf Mohammed, Ph.D.

Program Director, National Cancer Institute

Email: altaf.mohammed@nih.gov

Phone: 240-276-6082

Previous
Previous
July 28

NIH/NIBIB Division of Discovery Science and Technology SBIR Initiatives Focus on Biochemical Engineering

Next
Next
September 17

Engineering the next wave of immunotherapy